Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Badger gut bacteria could protect against tuberculosis
Dr Gutierrez isolated several types of natural gut bacteria from badger faeces.

Researchers assess impact of gut bacteria on BCG vaccine

New research led by the University of Surrey has revealed fresh insights into how gut bacteria could protect badgers and cattle from tuberculosis.

The research, funded by the Morris Animal Foundation, found that whilst gut bacteria from badgers could be decreasing the effectiveness of the BCG vaccine, it could also be killing the bacteria - M Bovis - that causes the disease.

Researchers say these good news/bad news findings, published in BMC Microbiology, could help to improve tuberculosis prevention.

It is already understood that some natural gut bacteria produce substances that kill off their competitors or make the gut a hostile place for them. To see if this might be occurring in the badger gut too, researchers
isolated several types of natural gut bacteria from badger faeces.

They found that some of these bacteria kill off the BCG vaccine, which could reduce its effectiveness. But it is not all bad news, as lead author Dr Jorge Gutierrez explains:

“As M. bovis is often excreted from infected badgers in their faeces, we might find a way to use these gut bacteria to kill M. bovis instead; a way of naturally reducing contamination of the badgers’ environment with the bacteria that cause TB.

“We also found the lactic acid from badgers was good at stimulating the badger’s immune system, which could be good news for improving the effectiveness of the vaccine.”

Dr Gutierrez adds that the findings could help to explain why the BCG vaccine has variable results in badgers ‘but also points to a possible future solution’. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.